VC Fund Dossiers

Atinum is old-school Korean VC royalty - they've been around since 1988 and have serious street cred with multiple unicorns like NIUM and Klook. They're not flashy but they know how to pick winners, especially in Korean tech. The fact that they've expanded to Singapore shows they're thinking beyond Korea's borders. However, like many Korean VCs, they can be pretty hands-off post-investment - don't expect the white-glove treatment of Silicon Valley funds. Their gaming and deep tech focus is solid, and their biotech picks like Celltrion show they can spot big pharma plays. If you're building in Korea or Southeast Asia and need a fund that understands local dynamics but has global ambitions, they're worth talking to.

Blue Lake Capital is the poster child for disciplined, research-driven China investing — which sounds great until you realize they're basically academic VCs who've gotten very lucky with timing. With 2 unicorns (Momenta, Meicai) and 2 IPOs (Jushuitan at $1.68B, Shanghai Hande at $404M), their track record looks solid, but founders should know they're dealing with methodical, process-heavy investors who love their spreadsheets more than gut instincts. Ray Hu's BCG background shows — expect lengthy due diligence, detailed market analysis, and partners who want to see every metric before they move. They're big on post-investment "empowerment" which translates to lots of check-ins about cashflow breakeven and business metrics. The upside? They genuinely understand enterprise software and manufacturing, stick with companies through multiple rounds, and have the patience for long development cycles that B2B businesses need.

BNK Venture Capital is the classic corporate VC that looks safer than it probably is. Formerly known as UQI Partners before being acquired by BNK Financial Group, they're basically a regional bank's attempt to play in venture. Their track record shows 12 IPOs and 2 acquisitions including Hyundai Steel and Skelter Labs, which sounds impressive until you realize most of these are probably Korean market exits that don't translate to Silicon Valley-style returns. With a team of 17 including 7 partners but reportedly not sitting on any company boards, they seem more like passive financial participants than hands-on value-add partners. The banking DNA probably means they're conservative, process-heavy, and focused on traditional due diligence over startup hustle.

CE Ventures is essentially a China-market access fund masquerading as a traditional VC. They help companies enter and accelerate in the Chinese market, find strategic investors in China, and manage relations there - Corephotonics insisted Kan sit on their board despite CreditEase only holding 1% because of his China market contribution. They perform 22 percentage points less than average on lead investments but commit exit 21 percentage points more often than other VCs. The real value prop isn't their capital - it's their CreditEase parent company's massive Chinese network. If you don't need China market entry, you're probably talking to the wrong fund. Fair warning: if your startup has 5+ founders, chances of getting funded are low.